Skip to content
10-Q

Quarterly Report

XTANT MEDICAL HOLDINGS, INC. XTNT

0001493152-26-022604

← back to feed
Filed
May 13, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 8, 2026 140.26M sh
Shares Diluted Q1 2026 · Mar 31, 2026 140.06M sh
Shares Diluted Q1 2026 · Mar 31, 2025 143.34M sh
Capex Q1 2026 · Mar 31, 2026 $194K
Capex Q1 2026 · Mar 31, 2025 $1.19M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$2.11M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $1.28M
Long Term Debt Q1 2026 · Mar 31, 2026 $8.1M
Long Term Debt Q1 2026 · Dec 31, 2025 $11.03M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $12.14M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $17.05M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $5.03M
Stockholders Equity Q1 2026 · Mar 31, 2026 $48.6M
Stockholders Equity Q1 2026 · Dec 31, 2025 $50.95M
Stockholders Equity Q1 2026 · Mar 31, 2025 $43.88M
Stockholders Equity Q1 2026 · Dec 31, 2024 $42.96M
Current Liabilities Q1 2026 · Mar 31, 2026 $18.77M
Current Liabilities Q1 2026 · Dec 31, 2025 $29.48M
Total Liabilities Q1 2026 · Mar 31, 2026 $29.4M
Total Liabilities Q1 2026 · Dec 31, 2025 $43.19M
Current Assets Q1 2026 · Mar 31, 2026 $62.62M
Current Assets Q1 2026 · Dec 31, 2025 $78.25M
Total Assets Q1 2026 · Mar 31, 2026 $78M
Total Assets Q1 2026 · Dec 31, 2025 $94.15M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.02
Eps Diluted Q1 2026 · Mar 31, 2025 $0.00
Eps Basic Q1 2026 · Mar 31, 2026 −$0.02
Eps Basic Q1 2026 · Mar 31, 2025 $0.00
Sga Expense Q1 2026 · Mar 31, 2026 $6.27M
Sga Expense Q1 2026 · Mar 31, 2025 $7.53M
Rd Expense Q1 2026 · Mar 31, 2026 $435K
Rd Expense Q1 2026 · Mar 31, 2025 $443K
Net Income Q1 2026 · Mar 31, 2026 −$3.09M
Net Income Q1 2026 · Mar 31, 2025 $58K
Operating Income Q1 2026 · Mar 31, 2026 −$2.92M
Operating Income Q1 2026 · Mar 31, 2025 $1.06M
Gross Profit Q1 2026 · Mar 31, 2026 $11.97M
Gross Profit Q1 2026 · Mar 31, 2025 $20.24M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $8.91M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $12.66M
Revenue Q1 2026 · Mar 31, 2026 $20.88M
Revenue Q1 2026 · Mar 31, 2025 $32.9M